What's the difference between Tirzepatide and Semaglutide?
Tirzepatide is a metabolic & weight loss that dual glp-1 and gip receptor agonism tirzepatide simultaneously activates two incretin receptors: the glp-1 receptor and the gip receptor. while the glp-1 receptor component…. Semaglutide is a metabolic & weight loss that glp-1 receptor agonism and camp signaling semaglutide binds to the glp-1 receptor (glp-1r), a class b g-protein coupled receptor expressed on pancreatic beta cells, hypothalamic…. The two differ in mechanism, half-life (~5 days (approximately 120 hours), enabled by C20 fatty diacid albumin-binding modification vs ~7 days (168 hours), enabled by C18 fatty diacid albumin-binding modification), and typical dose range.
Which has the longer half-life, Tirzepatide or Semaglutide?
Tirzepatide has a half-life of ~5 days (approximately 120 hours), enabled by C20 fatty diacid albumin-binding modification. Semaglutide has a half-life of ~7 days (168 hours), enabled by C18 fatty diacid albumin-binding modification. Longer half-lives generally mean less frequent dosing but slower on/off kinetics.
Which is cheaper, Tirzepatide or Semaglutide?
Current lowest live price on BodyHackGuide: Tirzepatide from $49.00, Semaglutide from $39.00. Prices are pulled from the vendor listings tracked on BHG and change frequently — see the compare tables on each compound page for the current set of offers.
Can you stack Tirzepatide and Semaglutide?
Stacking depends on mechanism overlap, safety profile, and goals. Tirzepatide and Semaglutide should only be stacked after reviewing each compound's individual protocol page, side effect profile, and any published interaction data. Use the BodyHackGuide stack builder for a structured review before combining research compounds.
Is tirzepatide stronger than semaglutide?
Yes, in head-to-head data. SURMOUNT-5 directly compared tirzepatide max-tolerated to semaglutide max-tolerated over 72 weeks: 20.2% body-weight loss on tirzepatide vs 13.7% on semaglutide. The dual GIP + GLP-1 mechanism beats the single GLP-1 mechanism on raw weight-loss output at every published dose pair.
Can you switch from semaglutide to tirzepatide?
Yes — most users transition by holding the last semaglutide dose, waiting 1-2 weeks, then starting tirzepatide at 2.5 mg weekly and escalating from there. Direct dose-matching doesn't work cleanly because the receptor profiles differ. Expect ~2-3 weeks of mild GI re-flare during the transition. Weight loss typically resumes within 4-6 weeks of starting tirzepatide.
What's the difference between Ozempic, Wegovy, and Mounjaro/Zepbound?
Ozempic and Wegovy are both semaglutide — Ozempic is the T2D brand (caps at 1.0 mg/wk), Wegovy is the obesity brand (goes to 2.4 mg/wk). Mounjaro and Zepbound are both tirzepatide — Mounjaro for T2D, Zepbound for obesity, both dose-identical up to 15 mg/wk. Insurance often only covers the T2D brands; obesity brands require coverage that includes anti-obesity medication or out-of-pocket.
Which has fewer side effects, tirzepatide or semaglutide?
Slight edge to semaglutide for fewer GI side effects in head-to-head data. In SURMOUNT-5, the GI-related discontinuation rate was ~6% on tirzepatide vs ~4% on semaglutide. Both have near-identical front-end nausea (40-50%) and vomiting (15-25%) profiles — tirzepatide's slightly higher discontinuation is likely tied to the higher weight-loss intensity rather than a unique mechanism.
Can you stack tirzepatide and semaglutide?
No. Both fully saturate the GLP-1 receptor. Combining them doubles the side effect burden with no additive efficacy. If you're on semaglutide and want more weight loss, switch to tirzepatide — don't stack. For triple-agonist coverage, retatrutide (Phase 3) adds the glucagon arm that neither of these has.
